Practical utility of amyloid and FDG-PET in an academic dementia center. - Wikidata - awgldk - TriplyDB

Practical utility of amyloid and FDG-PET in an academic dementia center.

Practical utility of amyloid and FDG-PET in an academic dementia center.

http://www.wikidata.org/entity/Q37518041

about

Future Directions in Imaging Neurodegeneration.Communicating mild cognitive impairment diagnoses with and without amyloid imaging.Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.Brain biopsy in neurologic decline of unknown etiology.Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease.Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting.Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Diagnostic impact of [18F]flutemetamol PET in early-onset dementia.Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers.Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada.Patient and caregiver reactions to clinical amyloid imaging.Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease.Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?Patient and Caregiver Assessment of the Benefits From the Clinical Use of Amyloid PET Imaging.Molecular cardiovascular imaging is ready for prime time: almost there.Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mi Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET.Effectiveness of Florbetapir PET Imaging in Changing Patient Management.Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes.A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer's Disease.

P2860

Q31162702-88825C9E-19CF-4366-8CB0-41BEAA5999EE Q33640373-F1CB6540-D028-4387-A040-2C2371B7083C Q34988649-4EB86DEA-8773-40FC-9EE0-28801EBE8809 Q35236240-6C452EE9-2713-4CCA-B092-5A449EA549B4 Q35735066-E179DE23-4B35-4E90-9EA9-3CF30131B62F Q35765058-A1645E15-B6B8-4544-9C19-9FACAA6173E3 Q35896890-30678C44-4DFC-4571-9892-00D670F66040 Q37220632-F2162379-8A75-4E62-9621-C964696C27AC Q37589384-D2B438BA-54A4-4EA6-A78B-129F3308A146 Q38877410-6DFB0A9E-F9FE-43AA-8898-0D2070B74625 Q38903262-AE416DA2-F821-435B-94E4-1AEFD1C35C84 Q39160016-49442EAC-2C73-4AA6-A08D-403913D7518D Q39644582-76FAC23A-A76B-493A-945E-8E771AEFA7EA Q39775407-CEC4D213-AD93-480D-8BD3-529B1C13EEA8 Q46431433-3B93D4B2-4AF4-4551-B7A9-A31D07B98F2C Q48071012-0851B462-6A02-4989-8AE8-74F834D8D94C Q48123795-CBAAD2C3-9D2B-4D14-B88E-6D03BE69B8C6 Q49971625-D83850FA-6A7F-4D09-9E75-01381AE05EEB Q50348918-C09E8D8F-F6C3-4631-A51B-C790AC2B17C1 Q50700908-0C7A75E5-04FB-4F33-8488-1E05BA2329DD Q54980020-2B3CA69F-34ED-4852-9250-512D92E0B8E1

P2860

Practical utility of amyloid and FDG-PET in an academic dementia center.

http://www.wikidata.org/entity/Q37518041

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Practical utility of amyloid and FDG-PET in an academic dementia center.

@en

Practical utility of amyloid and FDG-PET in an academic dementia center.

@nl

type

label

Practical utility of amyloid and FDG-PET in an academic dementia center.

@en

Practical utility of amyloid and FDG-PET in an academic dementia center.

@nl

prefLabel

Practical utility of amyloid and FDG-PET in an academic dementia center.

@en

Practical utility of amyloid and FDG-PET in an academic dementia center.

@nl

P1433

Q37518041-C81C8EE7-E92A-4152-A2C0-74C1880C0E4C

P1476

Q37518041-DADC035A-40A1-4867-A207-D6A078FA7CA1

P2093

Q37518041-11A6A03C-AFC3-4912-8028-2DDA2EEDAE6C

Q37518041-2F14F387-FD22-4D9B-90FF-4D0C8D2B6EC7

Q37518041-3217229A-56EE-4A16-8B7A-C0103627ECBF

Q37518041-322C539C-C723-4C91-9155-C7B71D73BCD3

Q37518041-3A2FE188-48D6-47A6-87E3-349AA0474C03

Q37518041-3F27BF36-DA11-4B25-8341-F5CAA079913A

Q37518041-579CF857-67E7-4711-A7F9-0F86B03BE072

Q37518041-5DF1163B-32DE-4A55-8128-F05210966F31

Q37518041-9C16C8B7-911D-46C4-8B55-D7B89C40BCA6

Q37518041-A08A5A54-AEF4-43B1-89B5-EC8A72F06AF0

P2860

Q37518041-00D5C241-7BF4-4B1A-8AD4-E44739FE2A87

Q37518041-05E93D76-33FD-42F2-9D94-31A31946963D

Q37518041-10A16BC7-E7ED-45D2-9F0F-227E1C57E7EA

Q37518041-1908D5BB-D892-4580-A69B-8796CE9B128A

Q37518041-1EFC2A44-3C6B-45CA-B763-7DB0198245AD

Q37518041-1F128EF7-CAD7-4496-A235-796AA5B1511C

Q37518041-233983A6-12FA-4682-8091-0ACFF265A9C7

Q37518041-282F88B0-2F94-449F-BCB0-3A1C4A064520

Q37518041-28693605-66E8-4BCA-AF6E-8C2A826BB63D

Q37518041-2CAEEFA0-55A3-489A-A753-69A61E4295CB

P304

Q37518041-4073D923-F14B-4BDA-8596-25016C2C0D2D

P31

Q37518041-E4B7CF8B-09FB-484A-9F94-082DB93565A1

P356

Q37518041-705F3F1B-8971-4CCA-ABE9-90BF857B6FEF

P407

Q37518041-99F6AF94-4FEB-4D03-AC92-2CEDF30CF7D2

P433

Q37518041-CEB8B091-3B32-4113-8F49-8B3358C9302F

P478

Q37518041-AB77F344-A7D8-4228-B83C-607BF1EACE80

P50

Q37518041-1CB7738B-DDDA-4E18-BE16-E22974FC2524

Q37518041-56D0195F-33C2-488E-B102-4216A6950F9D

Q37518041-6F277EF4-C849-4D13-9F3E-EA917E3F247D

Q37518041-BBC74BA1-7EA3-4CE3-8094-138B14AB58A4

Q37518041-D67C9103-C8AD-4BA8-8767-D2EFA13830A9

Q37518041-DDF8DA21-1ED7-414B-AD26-35AC5958D5C1

Q37518041-E8DA2363-5400-43E3-9C97-52B43A10A13A

P577

Q37518041-3369AB07-054B-46F0-B969-F3A69D0E2BD6

P698

Q37518041-07475CDC-777F-4FA3-9563-A4FA2DC5B6C2

P921

Q37518041-2FA011F4-DFD9-492D-A9C3-7DA140B46E22

P932

Q37518041-7E095C55-B86D-4771-84BC-DB96F640F58F

P356

WNL.0000000000000032

P1433

P1476

Practical utility of amyloid and FDG-PET in an academic dementia center.

@en

P2093

Benno Gesierich

http://www.w3.org/2001/XMLSchema#string

Eric J Huang

http://www.w3.org/2001/XMLSchema#string

Howard J Rosen

http://www.w3.org/2001/XMLSchema#string

James P O'Neil

http://www.w3.org/2001/XMLSchema#string

Jayne Hagen

http://www.w3.org/2001/XMLSchema#string

Joel H Kramer

http://www.w3.org/2001/XMLSchema#string

Lea T Grinberg

http://www.w3.org/2001/XMLSchema#string

Maya Henry

http://www.w3.org/2001/XMLSchema#string

Mustafa Janabi

http://www.w3.org/2001/XMLSchema#string

Pascual Sánchez-Juan

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of primary progressive aphasia and its variants

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Clinicopathological correlations in corticobasal degeneration

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

Mild cognitive impairment as a diagnostic entity

Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia

The neuropathology of older persons with and without dementia from community versus clinic cohorts.

P304

230-238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000000032

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P50

Maria Luisa Gorno-Tempini

Bruce L. Miller

John Q. Trojanowski

Harry V Vinters

Gil D Rabinovici

P577

2013-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24353340

http://www.w3.org/2001/XMLSchema#string

P921

P932

3902757

http://www.w3.org/2001/XMLSchema#string